Using the polygenic risk score for targeted prostate cancer screening
Jana McHugh, MD, of The Institute of Cancer Research, London, UK, gives a brief background of the BARCODE1 (NCT03857477) pilot…
Related Articles
BTOG 2024 insights & future directions: a comprehensive approach to thoracic malignancies
Sanjay Popat, from The Royal Marsden NHS Foundation Trust in London, UK, shares his enthusiasm for the BTOG 2024 congress in Belfast, UK, which gathered…
VJOncology – The video journal of oncology
The Video Journal of Oncology (VJOncology) is an independent, global, open-access video journal, dedicated to providing trusted and up-to-date information in order to improve the…
VJOncology – The video journal of oncology
The Video Journal of Oncology (VJOncology) is an independent, global, open-access video journal, dedicated to providing trusted and up-to-date information in order to improve the…
What are some remaining challenges in testicular cancer?
Ciara Conduit, FRACP, MBBS, PGCert MEd, Peter MacCallum Cancer Centre, Melbourne, Australia, discusses unmet needs in testicular cancer, including mental health issues such as stress…
VJOncology – The video journal of oncology
The Video Journal of Oncology (VJOncology) is an independent, global, open-access video journal, dedicated to providing trusted and up-to-date information in order to improve the…
VJOncology – The video journal of oncology
The Video Journal of Oncology (VJOncology) is an independent, global, open-access video journal, dedicated to providing trusted and up-to-date information in order to improve the…
VJOncology – The video journal of oncology
The Video Journal of Oncology (VJOncology) is an independent, global, open-access video journal, dedicated to providing trusted and up-to-date information in order to improve the…
VJOncology – The video journal of oncology
The Video Journal of Oncology (VJOncology) is an independent, global, open-access video journal, dedicated to providing trusted and up-to-date information in order to improve the…
Highlights in colorectal cancer at ASCO GI 2024
In this week’s podcast by VJ Oncology, six leading experts share their insights on cutting-edge developments in colorectal cancer screening…
Enhancing targeted radionuclide therapy with nanoparticles
Debjani Pal, PhD, Oak Ridge National Laboratory, Oak Ridge, TN, discusses the emergence of targeted radionuclide therapy (TRT) for personalized cancer treatment by delivering radiation…